Global ePedigree software market to grow at a CAGR of 26.95% during the period 2018-2022.
The report has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
One trend in the market is high-tech developments to smarten the pharma supply chain. Drug counterfeiting is a worldwide phenomenon. The general fake medication industry is assessed to be worth billions of dollars. This issue has been existing for a long time, primarily due to the lack of quality control in the complex pharma supply chain. Drug redirection, forging, and other such issues have been developing at a disturbing rate.
According to the report, one driver in the market is rising requirements for serializability to tackle counterfeiting. Drug counterfeiting is a worldwide phenomenon. This issue has been existing for decades, and the situation is worse than ever due to the proliferation of Internet sales, inefficient supply chains, and the general lack of stringent regulations. The overall counterfeit drug market is estimated to be worth billions of dollars, with countries such as India and China being the manufacturing hubs for the counterfeit drug market.
Key Topics Covered:
Part 01: Executive Summary
Part 02: Scope of the Report
Part 03: Research Methodology
Part 04: Market Landscape
Part 05: Market Sizing
Part 06: Five Forces Analysis
Part 07: Market Segmentation by Deployment
Part 08: Customer Landscape
Part 09: Regional Landscape
Part 10: Decision Framework
Part 11: Drivers and Challenges
Part 12: Market Trends
Part 13: Vendor Landscape
Part 14: Vendor Analysis
For more information about this report visit https://www.researchandmarkets.com/research/g3s9ln/global_epedigree?w=4